Literature DB >> 32873515

The Use of Three-dimensional Visualization Techniques for Prostate Procedures: A Systematic Review.

Shu Wang1, James Frisbie1, Zachery Keepers1, Zachary Bolten1, Anjana Hevaganinge2, Emad Boctor3, Simon Leonard4, Junichi Tokuda5, Axel Krieger6, Mohummad Minhaj Siddiqui7.   

Abstract

CONTEXT: As an emerging technique, three-dimensional (3D) visualization has become more popular and can facilitate education, training, surgical planning, and intraoperative guidance for prostate cancer surgery.
OBJECTIVE: In this review, we aim to present the impact of 3D printing, virtual reality (VR), and augmented reality (AR) techniques for prostate cancer procedures, specifically prostate biopsy and radical prostatectomy (RP). EVIDENCE ACQUISITION: A systematic review was performed by two investigators according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) criteria. EVIDENCE SYNTHESIS: A total of 541 papers were identified in PubMed, Scopus, and Embase. Of these, 53 studies were identified for detailed review and 25 were qualified. Two more studies were identified from the references; thus, 27 studies were finally included in this systematic review. Nine papers reported on the use of 3D reconstructed models, mainly in education/training and intraoperative guidance; nine reported on VR, focusing on simulation training model and intraoperative guidance; and nine reported on AR technique with its best indication for surgical guidance in robotic RP.
CONCLUSIONS: Three-dimensional visualization techniques have gradually been introduced and developed in prostate procedures, and demonstrate potential utility not only for education/training, but also for surgical planning and intraoperative guidance. Prospective studies are needed to demonstrate clinical utility and validation of these technologies. PATIENT
SUMMARY: Despite low-quality evidence, promising signals were identified to demonstrate that three-dimensional visualization could help facilitate prostate procedures, in terms of education/training, surgical planning, and intraoperative guidance. It is still in a very early stage, and more studies need to be conducted to justify its widespread use.
Copyright © 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Augmented reality; Prostate biopsy; Prostatectomy; Three-dimensional printing; Virtual reality

Mesh:

Year:  2020        PMID: 32873515     DOI: 10.1016/j.euf.2020.08.002

Source DB:  PubMed          Journal:  Eur Urol Focus        ISSN: 2405-4569


  4 in total

1.  The impact of 3D models on positive surgical margins after robot-assisted radical prostatectomy.

Authors:  Cristian Fiori; Francesco Porpiglia; Enrico Checcucci; Angela Pecoraro; Daniele Amparore; Sabrina De Cillis; Stefano Granato; Gabriele Volpi; Michele Sica; Paolo Verri; Alberto Piana; Pietro Piazzolla; Matteo Manfredi; Enrico Vezzetti; Michele Di Dio
Journal:  World J Urol       Date:  2022-07-05       Impact factor: 3.661

2.  Assessment of a novel smartglass-based point-of-care fusion approach for mixed reality-assisted targeted prostate biopsy: A pilot proof-of-concept study.

Authors:  P Sparwasser; M Haack; L Frey; K Boehm; C Boedecker; T Huber; K Stroh; M P Brandt; R Mager; T Höfner; I Tsaur; A Haferkamp; H Borgmann
Journal:  Front Surg       Date:  2022-07-22

3.  Domain adaptation for segmentation of critical structures for prostate cancer therapy.

Authors:  Anneke Meyer; Alireza Mehrtash; Marko Rak; Oleksii Bashkanov; Bjoern Langbein; Alireza Ziaei; Adam S Kibel; Clare M Tempany; Christian Hansen; Junichi Tokuda
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.379

Review 4.  The current and possible future role of 3D modelling within oesophagogastric surgery: a scoping review.

Authors:  Henry Robb; Gemma Scrimgeour; Piers Boshier; Anna Przedlacka; Svetlana Balyasnikova; Gina Brown; Fernando Bello; Christos Kontovounisios
Journal:  Surg Endosc       Date:  2022-03-11       Impact factor: 3.453

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.